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Abstract  30 
Objectives. Decreased muscle mass is a major contributor to age-related morbidity and strategies to 31 
improve muscle regeneration during ageing are urgently needed. Our aim was to identify the subset of 32 
relevant microRNAs (miRNAs) that partake in critical aspects of muscle cell differentiation, 33 
irrespective of computational predictions, genomic clustering or differential expression of the 34 
miRNAs.   35 
Methods. miRNA biogenesis was deleted in primary myoblasts using a tamoxifen-inducible CreLox 36 
system and combined with an add-back miRNA library screen. RNA-seq experiments, cellular 37 
signalling events and glycogen synthesis along with miRNA inhibitors were performed in human 38 
primary myoblasts. Muscle regeneration in young and aged mice was assessed using the cardiotoxin 39 
(CTX) model. 40 
Results. We identified a hierarchical non-clustered miRNA network consisting of highly (miR-29a), 41 
moderately (let-7) and mildly active (miR-125b, miR-199a, miR-221) miRNAs that cooperate by 42 
directly targeting members of the focal adhesion complex. Through RNA-seq experiments comparing 43 
single versus combinatorial inhibition of the miRNAs, we uncovered a fundamental feature of this 44 
network, that miRNA activity inversely correlates to miRNA cooperativity. During myoblast 45 
differentiation, combinatorial inhibition of the five miRNAs increased activation of focal adhesion 46 
kinase (FAK), AKT and p38 mitogen-activated protein kinase (MAPK), and improved myotube 47 
formation and insulin-dependent glycogen synthesis. Moreover, antagonizing the miRNA network in 48 
vivo following CTX-induced muscle regeneration enhanced muscle mass and myofiber formation in 49 
young and aged mice. 50 
Conclusion. Our results provide novel insights into the dynamics of miRNA cooperativity and 51 
identify a miRNA network as therapeutic target for impaired focal adhesion signalling and muscle 52 
regeneration during ageing.   53 
 54 
 55 
 56 
 57 
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 58 
1. Introduction 59 
Skeletal muscle comprises 40% of whole body mass and plays a critical role in the overall health of 60 
humans [1]. It not only ensures movement, posture, and stability, but also regulates heat production 61 
and whole body metabolism [2]. After 40 years of age, muscle mass starts to decline by approximately 62 
8% per decade [3]. Loss of muscle mass during ageing, or sarcopenia, is a key contributor to adverse 63 
events in the elderly such as falls, disability and death, which are summarized under the term frailty 64 
[4]. Sarcopenia affects 5-13% of seniors age 60 – 70 years and up to 50% of seniors aged more than 65 
80 years [5]. It is therefore important to understand the mechanisms of muscle formation and to 66 
develop strategies that help to maintain muscle mass and function throughout life. 67 
 68 
A vital requirement for skeletal muscle is its capacity to contract. To prevent muscle damage during 69 
contraction, the contractile apparatus is tightly connected to the extracellular matrix (ECM) through 70 
the costamere, a sarcolemmal lattice [6]. The costamere is comprised of the focal adhesion complex 71 
and the dystrophin glycoprotein complex that connect the sarcolemma to the extracellular matrix. 72 
Moreover, both protein complexes are interconnected and linked to the Z disc of the sarcomere. The 73 
periodicity of the costamere ensures an even distribution of force transduction from the muscle fiber to 74 
the ECM during contraction. Focal adhesion kinase (FAK, encoded by PTK2) is a non-receptor 75 
tyrosine kinase that acts as a mechanosensor at the core of the focal adhesion complex and receives 76 
signals from the ECM via integrins [7]. FAK integrates extracellular signals from the ECM and 77 
multiple growth factors to elicit the activation of anti-apoptotic pathways intracellularly. 78 
Unsurprisingly, FAK signaling is stimulated by exercise [8] as well as skeletal muscle hypertrophy 79 
[9]. However, FAK is also crucial for muscle stem cell differentiation as it is activated early in 80 
differentiating myoblasts [10-12] and can activate pathways which drive the myogenic differentiation 81 
program such as phosphatidylinositol 3-kinase (PI3K) and p38 mitogen-activated protein kinase 82 
(MAPK) signaling [13-15].  83 
 84 
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MicroRNAs (miRNAs) are a family of short non-coding RNA molecules that are potential therapeutic 85 
targets to improve skeletal muscle mass and function. miRNAs impact the protein output of a cell in a 86 
unique manner. Typically, one miRNA binds many of its target genes through the seed motif, 6 87 
nucleotides at its 5`-end, which recognizes the miRNA response elements (MREs) in the 3`-88 
untranslated regions (UTRs) of mRNAs [16]. miRNA binding leads to decapping of the mRNA, 5`-to-89 
3`-decay and a subsequent decrease in protein output [17; 18]. Although the effect of miRNAs on their 90 
target genes is typically modest, miRNAs have been assigned important functions in diverse biological 91 
aspects such as cancer [19], metabolism [20], genetic noise cancellation [21], biomarkers [22] and as 92 
therapeutic targets in a wide range of diseases [23]. Skeletal muscle formation has become an essential 93 
paradigm in understanding the role of miRNAs in the processes of development and differentiation. 94 
Over the last decade, miRNAs have emerged as powerful regulators of myogenesis [24] and aberrant 95 
expression of miRNAs underlie various skeletal muscle diseases [25]. Global loss of miRNAs by 96 
deletion of essential components of the miRNA biosynthesis pathway, such as the RNAse Dicer, has 97 
underscored the role of miRNAs during the development of skeletal muscle. Deletion of dicer at 98 
embryonic days 10.5-12.5 (MyoDCre x Dicerfloxflox) [26] or in satellite cells in adult mice (Pax7CreER/+ x 99 
Dicerfloxflox) [27] severely decreased muscle fiber formation.  100 
 101 
Cooperativity is emerging as an important determinant of miRNA function that can enhance target 102 
gene regulation. Co-regulation of target genes by a group of miRNAs can result in stronger effects 103 
than achieved by individual miRNAs alone depending on the distance of the MREs [28; 29]. 104 
Accordingly, computational workflows that predict miRNA cooperativity at the target gene level 105 
indicate that miRNA cooperativity might be more frequent than previously anticipated and could 106 
affect thousands of human genes [30]. miRNA cooperativity is not only being discovered by target 107 
gene predictions, but also by the localization of miRNA clusters within the genome. miRNA clusters 108 
are polycistronic and form one long primary transcript (pri-miRNA) from which single miRNA 109 
precursors (pre-miRNAs) are cleaved [31]. MiRNAs that arise from clusters exhibit similar expression 110 
patterns, although their individual abundance can vary substantially [32; 33]. Different miRNA 111 
clusters can contain miRNA paralogs indicating a role of gene duplication in their evolution. When 112 
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clusters are defined as miRNAs separated by a distance of less than 3000 nucleotides, an estimated 113 
42% of human miRNAs appear in clusters of more than two, usually two to three, miRNAs [34]. In a 114 
different study, 146 human miRNAs were identified to form 51 clusters [35]. The true number of 115 
miRNA clusters might be even higher, since the abundance of miRNA sequences can correlate over a 116 
distance of up to 50000 nucleotides [36]. Large scale computational analysis predicted the presence of 117 
> 400 miRNA clusters in the human genome [37]. Regardless of the exact numbers, miRNA clustering 118 
is higher in the genome than expected at random, suggesting that the coexpression of miRNAs and 119 
miRNA cooperativity provide an important evolutionary advantage. 120 
 121 
miRNA cooperativity provides unique opportunities for enhanced target gene regulation and miRNA 122 
function and its complex dynamics are slowly beginning to be unraveled. To uncover miRNA 123 
cooperativity in an unbiased and systematic fashion, irrespective of genomic clustering or the 124 
differential expression of miRNAs, we genetically deleted miRNA biosynthesis in primary muscle 125 
cells during differentiation. We identified a small set of miRNAs which targets the focal adhesion 126 
complex and which negatively influences the differentiation of myogenic progenitors in vitro and in 127 
vivo. We demonstrate that this hierarchical non-clustered network, consisting of miRNAs with varying 128 
degrees of activity, engage in target gene cooperativity. Finally, we provide evidence that targeting 129 
such a network could be used therapeutically to improve regeneration in the aged muscle.  130 
 131 
2.Results 132 
2.1.Genetic deletion of DGCR8 in primary myoblasts and add-back of a small group of miRNAs 133 
significantly regulates the focal adhesion gene cluster. To identify signaling pathways 134 
interconnected to the miRNA pathway in skeletal muscle cells, we developed a genetic screening 135 
platform based on the depletion of myoblasts of all miRNAs and subsequently screening for gene 136 
regulation following miRNA add-back (Suppl.Fig.1). We chose to work with miRNA-depleted cells to 137 
avoid any potential redundancy of gene regulation by miRNA families and cooperativity of miRNAs. 138 
To achieve this aim, we generated the transgenic mouse line Pax7CE x Dgcr8flox/flox and isolated 139 
primary myoblasts from skeletal muscle based on positive selection for α7-integrin [33]. We chose to 140 
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delete DGCR8 since this RNA-binding protein is necessary for pri-miRNA processing, but not 141 
required for processing of exogenous RNA duplexes. The Pax7CE transgene contains a tamoxifen-142 
inducible Cre recombinase driven by the endogenous Pax7 promoter and allows for activation of Cre 143 
expression in myogenic progenitor cells [38; 39]. Deletion of Dgcr8 was induced by tamoxifen 144 
incubation and cells were harvested at different time points for analysis under proliferating conditions 145 
and during differentiation. Efficiency of tamoxifen-induced genomic recombination at exon 3 of the 146 
Dgcr8 allele was >95% (data not shown) and DGCR8 protein became undetectable 2 days after the 147 
tamoxifen treatment (Fig.1A). The expression of another important component of the miRNA 148 
pathway, argonaute 2 (AGO2), remained detectable throughout all time points tested (Fig.1A). 149 
Following loss of DGCR8, miRNA levels gradually decreased and dropped to less than 10% after 6 150 
days, at which point the onset of apoptosis was observed (Fig.1A). To avoid the influence of 151 
apoptosis, differentiation was subsequently induced at day 4 for 48h. Although Dgcr8-depleted 152 
myoblasts were able to form multinucleated myotubes, they displayed a markedly thinner myotube 153 
morphology (Fig.1B). To identify pathways affected by the loss of miRNA biosynthesis, we 154 
determined the global gene expression profile four days after Cre induction in Pax7CE x Dgcr8flox/flox  155 
myoblasts using Agilent mRNA microarrays. At this time point, 458 transcripts were upregulated and 156 
235 transcripts were downregulated >2-fold with a p-value <0.05. The most significant regulated 157 
KEGG pathway was “focal adhesion” with a p-value of 3.2E-9 (Fig.1C). This cluster contained 15 158 
genes upregulated in the DGCR8 knockout cells and we confirmed regulation of 10 of these genes 159 
using qRT-PCR (Fig.1D). The results of the complete KEGG pathway analysis is shown in Suppl. 160 
Table 1. Next we selected two genes as readouts for our miRNA screen, thrombospondin-1 (Thbs-1), 161 
as part of the KEGG pathway “focal adhesion”, and plasminogen activator inhibitor-1 (Pai-1), an 162 
inflammatory marker known to positively correlate with Thbs-1 [40]. Indeed, we reconfirmed a robust 163 
and time-dependent upregulation of both genes upon deletion of Dgcr8 in myoblasts (Suppl.Fig.2). 164 
Additionally, we performed small RNA deep sequencing in wild type myoblasts to identify the highest 165 
expressed miRNAs in muscle cells. The top 85% of all miRNAs expressed in at least one myoblast 166 
culture were used to generate a library for our screen (Suppl.Fig.3). miRNA seed families were 167 
represented by one member, e.g. let-7c for the let7 family, and three miRNA sequences were excluded 168 
7 
 
since they were not conserved between mice and humans (mmu-miR-351-5p, mmu-miR-434-5p and 169 
mmu-miR-541-5p). Although not part of the top 85% of miRNAs in myoblasts, we included the 170 
muscle-specific miRNAs miR-1, miR-133, miR-206 and miR-499. Since we only studied miRNAs 171 
that are conserved between mice and humans we omitted the prefix “mmu” or “hsa” before the 172 
miRNA name throughout this paper. miRNAs from the library were transfected into Dgcr8-depleted 173 
myoblasts and the expression of Thbs-1 and Pai-1 was analyzed under both proliferating conditions 174 
(MB) and during differentiation (MT) (Suppl.Fig.4A). First, we ranked the miRNAs based on 175 
downregulation of the reporter genes in two independent library transfections. We then selected those 176 
miRNAs that scored for downregulation of Thbs-1 or Pai-1 in the top 10 of all miRNAs independent 177 
of differentiation (in both MB and MT). Six miRNAs fulfilled these criteria as highlighted in Suppl. 178 
Fig.4B. This set of six miRNAs was able to rescue the marked morphological alterations of Dcgr8 KO 179 
myotubes (Fig.2A). Importantly, adding back each of the six miRNAs alone was not sufficient to 180 
rescue cell morphology (Fig.2B). Finally, we assessed the ability of this group of miRNAs to rescue 181 
the loss of all miRNAs in muscle cells at the molecular level using RNA deep sequencing. Consistent 182 
with the microarray analysis on proliferating myoblasts, the KEGG pathway “focal adhesion” was 183 
again the most significantly upregulated gene cluster in DGCR8 KO cells during differentiation. 184 
Importantly, this upregulation was reversed by the add-back of the six miRNAs (Fig.2C,D). Together, 185 
these results demonstrate that the miRNA pathway is strongly linked to focal adhesion signaling in 186 
myoblasts through a very limited set of miRNAs.  187 
 188 
2.2.miRNA cooperativity enhances differentiation and activates focal adhesion signaling in 189 
primary myoblasts from mice and humans. To further clarify the mechanisms and cooperativity of 190 
the identified set of miRNAs as well as its conservation between species, we turned to loss-of-function 191 
assays in wildtype skeletal muscle cells from mice and humans. Since miR-499 was not among the top 192 
85% of the most abundant miRNAs in myoblasts (Suppl.Fig.3), we continued with only five miRNAs 193 
with largely conserved expression levels in mouse and human primary myoblasts (Suppl.Fig.5). 194 
Inhibition of these five miRNAs in human myoblasts at the onset of differentiation specifically 195 
upregulated myogenin among the myogenic regulatory factors (MRFs) and strongly induced 196 
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embryonic myosin heavy chain (eMHC) at the mRNA and protein level (Fig.3A,B). Especially in the 197 
case of eMHC, this effect was most pronounced in the combination of all 5 antagomirs (Ant-5x) 198 
(Fig.3A,B). The same cooperative miRNA effect on MHC expression was observed during 199 
differentiation of primary myoblasts from mice (Suppl.Fig.6). We also transfected miRNA mimics 200 
into human myoblasts and analyzed the different stages of myogenic differentiation at the mRNA level 201 
(Suppl.Fig.7a). Interestingly, three out of the five miRNAs (let7, miR-199, miR-125) increased 202 
differentiation at the level of MyoD, myogenin or myosin heavy chain while miR-29a or miR-221 203 
overexpression had no effect. The combinatorial overexpression overall caused no alterations in 204 
differentiation. We confirmed successful and marked overexpression for the single miRNAs as well as 205 
for their combination (Suppl.Fig.7b). These results are consistent with our previous data obtained in 206 
the DGCR8 KO cells where miRNA overexpression favored myotube formation and reveal a non-207 
symmetrical effect of miRNA mimics and inhibitors during muscle cell differentiation. Our results are 208 
in line with published data of another miRNA network that acts during the differentiation of 209 
endothelial cells, where both gain and loss of function of the miRNAs displayed a non-symmetrical 210 
effect and affected differentiation in the same direction regardless of the manipulation [41]. We 211 
hypothesize that the complex equilibrium of a miRNA network during cellular differentiation requires 212 
controlled miRNA levels and that the marked overexpression of miRNAs cannot easily be compared 213 
with miRNA inhibitors under these conditions.  214 
To explore miRNA cooperativity at the level of the MYOG gene, we used the 3’UTR and the 215 
promoter region of myogenin in luciferase assays (Fig.3C). The myogenin 3’UTR was only regulated 216 
by miR-125 mimics, while the myogenin promoter responded to all single transfected antagomirs, 217 
albeit the strongest regulation was again observed for the Ant-5x combination. The rate of decay for 218 
myogenin mRNA did not differ between control and Ant-5x samples (Fig.3C). These data demonstrate 219 
that the set of miRNAs induces the transcription of myogenin upstream of its promoter activity, but 220 
does not affect myogenin mRNA degradation via binding to its 3`UTR. Time course experiments 221 
confirmed that Ant-5x accelerated myogenic differentiation,  causing a surge in the expression of 222 
myogenin followed by MHC 24 hours earlier compared to control human myotubes (Fig. 3D), and 223 
resulting in more pronounced myotube formation with increased complexity and an increased fusion 224 
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index (Fig.3E). Since depletion of the miRNA pathway significantly alters focal adhesion signaling in 225 
myoblasts and given that FAK influences muscle differentiation [10-12], we evaluated the activation 226 
of FAK following the inhibition of the five miRNAs. Indeed FAK phosphorylation was strongly 227 
induced during the differentiation of human myoblasts treated with Ant-5x as compared to control 228 
antagomir (Fig.3F). The phosphoinositide-3-kinase (PI3K)-Akt pathway and the p38 mitogen-229 
activated protein kinase (MAPK) are downstream of FAK signaling [13-15] and are both necessary for 230 
the initiation of the myogenic program [42]. Accordingly, phosphorylation of both AKT and p38 231 
MAPK was 2-fold higher in myotubes treated with the antagomir combination than control antagomir 232 
(Fig.3F). To investigate if enhanced phosphorylation of AKT also relates to improved muscle cell 233 
function, we measured insulin-dependent glycogen synthesis. Human myotubes transfected with Ant-234 
5x had heightened insulin sensitivity and produced significantly more glycogen when challenged with 235 
insulin than control antagomir treated myotubes (Fig.3G). Together, these results support our initial 236 
observation that focal adhesion signaling couples the miRNA pathway to the activation of the 237 
myogenic lineage program. Lastly, we tested the difference between silencing the selected five 238 
miRNAs compared to silencing the previous six miRNAs including miR-499. Immunoblot analysis of 239 
muscle differentiation and intracellular signaling showed that adding miR-499 antagomirs to Ant-5x 240 
did not further enhance the activation of the myogenic lineage program (Suppl. Fig.8) supporting the 241 
view that it is indeed the set of five miRNAs that is critical for muscle cell differentiation.     242 
 243 
2.3.Genome-wide analysis of miRNA cooperativity during human muscle cell differentiation 244 
reveals a hierarchical regulatory network of the focal adhesion complex. Our next aim was to 245 
investigate the level of cooperativity of the different miRNAs and compare the contributions of the 246 
miRNAs to muscle cell differentiation. Accordingly, we performed whole genome analysis using 247 
RNA-seq on differentiated human myoblasts treated with antagomirs either against the individual 248 
miRNAs or against all miRNAs (ant-5x). The circos plot of the significantly regulated genes for each 249 
antagomir and ant-5x provides an overview of the complex regulatory activity at the molecular level 250 
(Fig.4A). Strikingly, inhibition of all 5 miRNAs together regulated more genes than the inhibition of 251 
the individual miRNAs separately. This was observed for both the upregulated predicted target genes 252 
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of the miRNAs as well as the non-target genes indicating that gene regulation also occurred 253 
downstream of the predicted targets. Circos plot analysis also revealed the individual contributions of 254 
the miRNAs to the total number of regulated predicted target genes and non-target genes such that 255 
miRNA activity could be classified as highly active (miR-29a), moderately active (let-7) and mildly 256 
active (miR-125b, miR-199 and miR-221). The enrichment of predicted targets in the group of 257 
upregulated genes was only observed after single inhibition of miR-29a and let-7, the two most active 258 
miRNAs, but not after inhibition of the less active miR-125b, miR-199 or miR-221 (Fig.4B). 259 
However, the less active miRNAs strongly benefited from the combinatorial antagomir approach since 260 
predicted targets of miR-125b, miR-199 and miR-221 were highly enriched in the ant-5x condition, 261 
while the enrichment of miR-29a targets rather decreased (Fig.4B). These results indicate that only 262 
moderate and mildly active miRNAs engaged in target cooperativity. Similar results were obtained 263 
when we compared the effect size of target gene regulation after single antagomir versus 264 
combinatorial antagomir inhibition. Although targets of miR-29a were similarly regulated in both 265 
conditions, there was a slight increase in the upregulation of let7 targets after ant-5x, while the 266 
strongest effect size was observed for the target genes of miR-125b, miR-199a and miR-221 in ant-5x 267 
compared to the single antagomir treatments (Fig.4C). To gain further insight into the cooperativity of 268 
the miRNAs, we analyzed the cumulative distribution fractions (CDF) of their predicted target genes 269 
compared to non-targets (Suppl.Fig.9). Inhibition of miRNAs relieves repression of their predicted 270 
target genes compared to non-target genes, visualized as a right shift in CDF plots (Suppl.Fig.9A,B). 271 
To provide a better overview of the results, we plotted the log2-fold differences of the average CDFs 272 
of targets and non-targets for each antagomir condition (Suppl.Fig.9C), where increased CDF fold 273 
change reflects a larger average rightward shift of the group of predicted target genes compared to 274 
non-target genes and therefore a stronger inhibitory activity of the miRNA. Consistent with the 275 
observed enrichment of predicted miRNA targets shown in Fig.4B, miR-29a and let-7 had the largest 276 
CDF fold changes for their predicted target genes in antagomir-29a and antagomir-let7, respectively 277 
(Suppl.Fig.9C). Differences for mildly active miRNAs were more subtle or not detected. Next, we 278 
asked whether any of the miRNAs would show cooperativity at the target gene level which would 279 
manifest as an increase in the CDF fold difference in the ant-5x condition. Again, such evidence for 280 
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target gene cooperativity was only observed for the mildly active miRNAs, miR-125b/miR-221, miR-281 
125b/miR-199 and miR-221/miR-199 (Suppl.Fig.9C). Lastly, we searched for enrichment of Gene 282 
Ontology (GO) terms within the ant-5x group to recapitulate our initial observation linking the 283 
miRNA pathway to the focal adhesion complex. Consistent with the results obtained for Dgcr8 KO 284 
cells and the add-back experiments, the GO term focal adhesion was the most significantly enriched 285 
gene cluster in ant-5x (Fig.4D). The focal adhesion gene cluster contained a total of 145 genes, of 286 
which 30 genes could be categorized as potential direct targets by comparing predicted target genes 287 
lists with significantly upregulated genes after single and combinatorial antagomir inhibition (Fig.4E). 288 
Interestingly, also in this analysis, the mildly active miRNAs are predominantly connected to genes 289 
that are targeted by more than one miRNA. Together, our results support the view that the focal 290 
adhesion pathway is targeted during muscle cell differentiation by a hierarchical network of miRNAs 291 
with different degrees of activity, where miRNA activity inversely correlates with miRNA 292 
cooperativity.    293 
 294 
2.4.Improved skeletal muscle regeneration in young and aged mice by combinatorial miRNA 295 
targeting. Finally, we asked whether the miRNA network that we identified also enhances muscle 296 
regeneration in vivo. To this end, we injected the combination of Ant-5x or control antagomirs i.m. 297 
following CTX-induced muscle regeneration (Fig.5). The inhibition of the miRNA network 298 
significantly enhanced muscle mass and fiber formation in young mice (Fig.5A). Since focal adhesion 299 
signaling is defective during muscle regeneration in aged mice [15], we sought to test whether the 300 
inhibition of the miRNA network could also improve muscle formation in this pathological condition. 301 
Indeed, muscle regeneration was largely inhibited in aged mice compared to young mice 30 days after 302 
CTX injection (Fig.5B). Importantly, i.m.-injection of the miRNA inhibitors improved muscle weight 303 
and fiber formation in the aged mice. Together, these results reveal the utility of a miRNA network 304 
that regulates the focal adhesion complex to improve muscle formation in young and aged states 305 
(Fig.6). 306 
 307 
3.Discussion 308 
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Our study provides an unbiased and genome-wide approach that uncovered a hierarchical miRNA 309 
network during muscle cell differentiation. The focal adhesion complex is central to the integration of  310 
multiple extracellular signals for muscle health and we demonstrate that this complex is tightly 311 
connected to the miRNA pathway by a small set of miRNAs. The novelty of the miRNA network that 312 
we describe is its composition of non-clustered miRNAs, where miRNA activity is inversely 313 
proportional to target gene cooperativity. Importantly, combinatorial targeting of this miRNA network 314 
improved muscle regeneration in young and aged mice. 315 
 316 
We propose that within a miRNA network, miRNA activity inversely correlates to miRNA 317 
cooperativity. Predictions of miRNA cooperativity generally build upon the physical distance of 318 
miRNA binding sites on  the 3`UTR of mRNA targets, with optimal downregulation when sites are 319 
separated by 13 to 35nt [29]. Our data suggest an additional criteria which affects the likelihood of a 320 
miRNA to be involved in the co-regulation of target genes and that is the activity of the miRNA. A 321 
highly active miRNA, such as miR-29a, exerts its effect on numerous targets that become upregulated 322 
upon inhibition of the miRNA, while other miRNAs, such as miR-221 and miR-199, appear to be less 323 
active because inhibition of both miRNAs is required to successfully upregulate target genes. We 324 
speculate that high activity might be a function of affinity between miRNA and target, rather than the 325 
expression of the miRNA itself since miR-29a is less abundant in myoblasts than miR-125b, miR-199 326 
or let7 (Suppl.Fig 3,5). Thus, we reason that miRNA cooperativity hinges on the strength of the 327 
interaction between miRNA and target, such that the presence of a strongly engaged binding site will 328 
relieve the evolutionary pressure on the weak binding site of another miRNA on the same transcript, 329 
resulting on loss of target cooperativity for the active miRNA. Such a scenario, high affinity binding 330 
of miRNA and target, would be reminiscent of the interactions between miRNA and competing 331 
endogenous (ce) RNA, where the highly abundant ceRNA needs to harbor high affinity sites to detract 332 
miRNAs [43]. On the other hand, two or more equally engaged binding sites would have similar 333 
evolutionary pressures and co-evolve, resulting in the synergistic regulation of the target by multiple 334 
miRNAs and miRNA target cooperativity. Further experiments are necessary to support our 335 
hypothesis.  336 
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 337 
The five miRNAs that we identified to exert cooperativity do not belong to a common miRNA cluster 338 
nor do they share a common seed motif, different from previous reports of miRNA cooperativity. For 339 
example, miRNA cooperativity within skeletal muscle was shown for miRNA isomers that contain 340 
identical seed regions. miR-133a1/miR-133a2 or miR-208b/miR-499, are expressed from different 341 
genetic locations, but share their target recognition motif. In these cases only deletion of both miR-342 
133a alleles (miR-133a1/a2 double knockout) resulted in adult onset myopathy [44], while only 343 
deletion of miR-208b and miR-499 together caused substantial loss of type 1 myofibers in the soleus 344 
muscle [45]. Such functional redundancy was also demonstrated in the model organism C. elegans for 345 
the miR-58 family members that share the same 6-mer seed motif [46]. Outside skeletal muscle, 346 
miRNA cooperativity also occurs between members of the same miRNA cluster that do not share the 347 
same target genes. Serial genetic deletions of the miRNA alleles from the miR-17-92 cluster 348 
containing four different seed families or the two miR-200 clusters containing two different seed 349 
families have demonstrated functional cooperativity across seed conservation [47; 48]. Our findings 350 
emphasize that miRNA cooperativity can exist beyond miRNA clustering and miRNA isomers and 351 
might be more frequent than previously appreciated. We show that predicted target regulation 352 
increases when miRNAs are collectively inhibited, similar to the functional redundancy described 353 
above during other types of miRNA cooperativity. A feature of miRNA cooperativity is that some 354 
miRNAs contribute a small set of target genes, yet the phenotype is most pronounced when all 355 
miRNAs are inhibited collectively [47]. In agreement, we show that the predicted target genes within 356 
the focal adhesion gene cluster are not equally distributed between the miRNAs, with the bulk of the 357 
targets being regulated by miR-29a. Notably, our data also confirms that miRNA cooperativity not 358 
only enhances the degree of regulation of gene expression, but also regulates a larger number of genes 359 
than observed for single miRNAs [47].  360 
 361 
The role of individual miRNAs in skeletal muscle formation has been extensively studied and 362 
numerous miRNAs have been shown to participate in this process [24]. An inhibitory role during 363 
muscle cell differentiation was assigned to four of the five miRNAs identified in our miRNA library 364 
14 
 
screen. Single inhibition of miR-29a, let-7, miR-125b or miR-221 promotes muscle cell differentiation 365 
[33; 49-52], while the effects of inhibiting skeletal muscle miR-199a-5p are less clear [53]. 366 
Additionally, inhibition of let-7 by injection of miRNA inhibitors or transgenic expression of the let-7 367 
inhibitor Lin28 increases muscle mass in mice [54; 55]. This remarkable overlap provides further 368 
proof-of-concept for our study and underlines the potency of our assays to identify the few miRNAs 369 
from the total pool that partake in cooperativity to affect muscle cell differentiation. However, our 370 
study highlights the concept that these five miRNAs are integrated in a more complex regulatory 371 
network. 372 
 373 
Our results suggest that the set of five miRNAs cooperate at the level of the focal adhesion complex to 374 
inhibit myoblast differentiation. During differentiation of human muscle cells, at least 20% of the 375 
genes from the focal adhesion gene cluster are potential direct targets of these miRNAs. This number 376 
includes only the evolutionary conserved binding sites and is likely to be even higher considering all 377 
possible non-conserved binding sites. FAK signaling is crucial for skeletal muscle regeneration and 378 
insulin-sensitivity and, consequently, inhibition of the set of miRNAs in our study closely mirrored its 379 
activation. Satellite cell-specific FAK knockout mice have a 4-fold decrease in regenerating small-380 
diameter fibers 3 days after induction of muscle injury [12] and FAK is necessary for myotube 381 
formation [12; 56]. In contrast, combinatorial miRNA inhibition in our study enhanced muscle mass 382 
and fiber size during muscle regeneration and improved myotube formation. FAK activates the PI3K 383 
and p38 MAPK pathways and improves insulin action in muscle cells, such as insulin-stimulated 384 
GLUT4 translocation and glycogen synthesis [57-61]. Ant-5x treatment in our study increased 385 
phosphorylation of p38 MAPK and AKT and enhanced glycogen synthesis in response to insulin. At 386 
the onset of differentiation, PI3K/AKT and MKK6/p38 MAPK pathways converge at the chromatin 387 
level to initiate transcription of the myogenic lineage program [42]. Consistent with our results, it has 388 
been shown in two separate studies that forced activation of p38 MAPK through a constitutive active 389 
mutant of MKK6 resulted in accelerated differentiation of myoblasts and early induction of both 390 
myogenin and MHC [62; 63]. In addition, FAK translocation to the nucleus induced myogenin 391 
transcription by decreasing protein interactions on the myogenin gene promoter [64], in line with our 392 
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findings using the myogenin promoter-driven reporter assays. Furthermore, inhibition of FAK during 393 
muscle cell differentiation prevented the induction of myogenin expression [12]. Therefore, our results 394 
place the induction of the myogenic program by miRNA inhibition upstream of myogenin, driven by 395 
enhanced FAK signaling.   396 
 397 
During ageing, myogenic progenitors (MPs) are depleted in the adult muscle stem cell niche and 398 
muscle regeneration is impaired [65-68]. Decreased FAK signaling is associated with this regeneration 399 
defect since MPs from aged mice have lower FAK expression [15]. Furthermore, expression of the 400 
ECM member fibronectin is reduced in the aged stem cell niche of the skeletal muscle and integrin-401 
mediated signaling through fibronectin, FAK and p38 MAPK is subsequently downregulated [15]. In 402 
humans, upregulation of ECM genes is part of the adaptation to exercise in middle-aged and old 403 
subjects [69; 70], but older subjects failed to upregulate fibronectin expression upon exercise-induced 404 
muscle regeneration [71]. Our data reinforce the notion that regulation of focal adhesion signaling 405 
during ageing could be a valuable therapeutic approach.  406 
 407 
In vivo, inhibition of the set of 5 miRNAs during skeletal muscle regeneration resulted in increased 408 
muscle mass and fiber number. Our protocol carefully timed the antagomir injections to day 3 after 409 
CTX injection, a time point where we expected to target preferentially muscle formation and myofiber 410 
differentiation, but not MP proliferation. In fact, perturbations in p38 MAPK signaling during the 411 
early proliferative phase of muscle regeneration can have deleterious effects. For example, in aged 412 
mice, increased FGF2 and p38 MAPK signaling in proliferating MPs are associated with impaired 413 
asymmetric division and a depletion of the quiescent stem cell pool [65; 72]. Similarly, we have 414 
recently demonstrated that the genetic ablation of miR-29a in quiescent MPs decreases proliferation 415 
and subsequently muscle formation [33]. These results show that the timing of miRNA inhibition 416 
during muscle regeneration is likely critical to decide whether the predominant effect is on muscle cell 417 
proliferation or differentiation.  Our approach would be most valuable in stem cell therapy where the 418 
outcome is to increase myofiber formation, but not MP proliferation. 419 
 420 
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Therapeutically, combinatorial targeting of miRNAs is advantageous since it reduces the concentration 421 
of pharmacological miRNA inhibitors and off-target effects. This has been demonstrated in human 422 
glioblastoma cells where inhibition of either miR-10b or miR-21 enhances apoptosis and reduces cell 423 
invasiveness. The amount of inhibitors needed to produce a therapeutic response was dramatically 424 
decreased when miR-10b and miR-21 inhibitors were combined compared to the use of the inhibitors 425 
alone [73]. Furthermore, we speculate that by using minimal inhibitor concentrations to downregulate 426 
a ubiquitous group of miRNAs, the inhibition will be sufficient to cause biological effects only in the 427 
tissue that concomitantly expresses the miRNAs, with minimal side effects to other organs. 428 
Prospective experiments will address whether targeting the 5x miRNA combination selectively affects 429 
the differentiation of skeletal muscle instead of the differentiation of other types of stem cells. In 430 
addition, it is an intriguing possibility that tissue-specific phenotypes can emerge when multiple 431 
miRNAs are targeted in combination. For example, contrary to the effects that we and others have 432 
observed for skeletal muscle stem cell differentiation as discussed above, miR-29 and miR-125b 433 
enhanced differentiation of preadipocytes [74; 75], while  delivery of miR-125-5p, miR-199a-5p and 434 
miR-221 increased cardiomyocyte differentiation [76]. Furthermore, the 5x miRNA combination 435 
might be beneficially used as therapeutic intervention in various pathological conditions. miRNA 436 
microarray analysis of human skeletal muscle from 10 different primary muscular disorders reported 437 
upregulation of four out of the five 5xAnt-miRNAs (let-7 in 5/10, miR-125a in 6/10, miR-199a in 8/10 438 
and miR-221 in 10/10 primary muscular disorders) [25]. Strikingly, the most affected gene cluster in 439 
our study, the KEGG pathway “focal adhesion,” was also significantly regulated in 7 out of 9 primary 440 
muscular disorders [25]. The connection between the focal adhesion complex and the miRNA pathway 441 
might be more relevant for skeletal muscle diseases then previously appreciated.   442 
 443 
In summary, we have discovered miRNA cooperativity that is independent of miRNA clustering and 444 
seed conservation and which regulates focal adhesion signaling during muscle stem cell 445 
differentiation. Our approach provides an alternative to purely computational methods to uncover 446 
miRNA cooperativity and introduces the notion that the activity of a miRNA could determine its 447 
capacity to engage in miRNA cooperativity. The discovery of the tight connection between focal 448 
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adhesion and the miRNA pathway in muscle cells might lead to novel therapeutic protocols during 449 
ageing and other diseases where ECM-dependent signaling is altered.   450 
 451 
4.Methods 452 
4.1.Animals  453 
C57BL6/6J mice were obtained from Harlan (Netherlands), DCGR8flox/flox mice were kindly provided 454 
by M. Stoffel (Zurich), Pax7tm2.1(cre/ERT2) mice were obtained from Jackson (US) and aged mice and 455 
control littermates (C57Bl/6JRj) were obtained from Janvier Labs (France). Animals were housed in a 456 
pathogen-free animal facility on an inverted 12-hour light cycle and fed ad libitum with chow diet. For 457 
genotyping, genomic DNA was isolated from ear punches and analyzed using PCR. Primer sequences 458 
used were Dgcr8 Forward GACATCAATCTGAGTAGAGACAGG, Reverse 459 
CAGATGGTAACTAACCTGCCAACC, Pax7 Forward ACTAGGCTCCACTCTGTTCCTTC, 460 
Reverse GCAGATGTAGGGACATTCCAGTG. Muscle regeneration in the TA muscle was induced 461 
by injection of cardiotoxin (CTX) as previously described [32]. All animal studies were approved by 462 
the ethics committee of the Canton of Zurich Veterinary Office. 463 
 464 
4.2.Primary mouse and human myoblast cultures, apoptosis assay, western blotting and RNA 465 
decay 466 
Procedures for isolation of primary muscle cells from human and mouse skeletal muscle were 467 
performed as previously described [33]. Briefly, skeletal muscle tissue was subjected to collagen 468 
digestion and myogenic progenitors (MPs) were isolated using flow cytometry. Human MP isolation 469 
was based on CD56 expression and absence of CD15, CD31 and CD45 staining, while mouse MP 470 
isolation was based on the presence of a7-integrin and absence of Sca1, CD31 and CD45 staining. 471 
Cells were grown on collagen-coated plates in culture medium (1:1 v/v F10 nutrient mixture and 472 
DMEM (low glucose) containing 20% fetal bovine serum (FBS), 1% Penicillin/Streptomycin (P/S) 473 
and 5 ng/ml basic FGF (Invitrogen)). Tamoxifen was dissolved in 100% ethanol and diluted in growth 474 
media (final concentration 20 nM) for a 48 h incubation period on primary myoblasts. Differentiation 475 
was initiated when myoblasts reached subconfluency by changing the media to DMEM containing 2% 476 
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horse serum and 1% P/S. For apoptosis assays, myoblasts were trypsinized and resuspended in buffer 477 
(10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4), followed by incubation with an Alexa 478 
Fluor® 647-conjugated Annexin V phosphoserine sensitive antibody (Biolegend, #422201) and 479 
fluorescence detection by flow cytometry. For western-blotting, cell lysates were separated by SDS-480 
PAGE, transferred to PVDF membranes and proteins detected using primary antibodies for AGO2 481 
(1:1000 Wako, 2D4), desmin (1:1000 Sigma, D1033), DGCR8 (1:1500 Protein tech, 10996-1-AP), 482 
GAPDH (1:2000 Protein tech, 10494), adult myosin heavy chain (MHC, 1:100 DSHB, MF-20), 483 
myogenin (1:1000 Santa cruz, sc-12732), phospho p38 MAPK (1:1000 Cell Signaling 9211), p38 484 
MAPK (1:1000 Cell Signaling 9212), phospho AKT (1:1000 Cell Signaling S473), AKT (1:1000 Cell 485 
Signaling 2920) and phospho FAK (1:1000 Cell Signaling 8556). For RNA decay, cells were 486 
differentiated for 3 days, treated with 10ug/ml Actinomycin D (Sigma) for the indicated time, then 487 
processed for qRT-PCR. 488 
 489 
4.3.Immunofluorescence of primary myoblasts and skeletal muscle  490 
Primary muscle cells were fixed with 4% paraformaldehyde at room temperature for 5 min and 491 
washed with PBS. Cells were subsequently blocked and permeabilized for 1h (0.01% saponin, 1% 492 
BSA, 3% horse serum). Primary antibodies were incubated overnight at 4ºC and secondary antibodies 493 
incubated for 1h at room temperature (antibodies were used as indicated for western blotting except 494 
for anti-desmin [1:50, Abcam, ab8976]). Slides were mounted with DAPI (Vectashield) and visualized 495 
using Zeiss Axioplan2 imaging or Slide scanner Axio Scan Z1. The images were processed with 496 
Image J. Fusion index was calculated as the ratio of nuclei inside a myotube containing at least two 497 
nuclei compared to the number of all nuclei in the well. For skeletal muscle immunofluorescence, 498 
sections were processed as described in Mizbani et al. [32], incubated with anti-laminin antibody 499 
(1:500, Sigma L9393), imaged with a Leica CLSM SP8 and analyzed with Ilastic and ImageJ for fiber 500 
size and number.  501 
 502 
4.4.Antagomir and miRNA mimic transfections 503 
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miRNA mimic and inhibitor transfection was performed as previously described [33]. In brief, 504 
primary myoblasts were transfected using the Lipofectamin RNAimax protocol (Invitrogen) and 505 
human miRNA mimics (30 nM, Mission, Sigma-Aldrich) or miRNA inhibitors (24 nM, antagomirs 506 
[77]) (Mission, Sigma-Aldrich). In case of the combination of multiple mimics or antagomirs, the total 507 
concentration per well was always kept constant at 30 nM or 24 nM, respectively (same as in the 508 
control mimic/antagomir transfections). Antagomirs against the let-7 family consisted of a 1:1 mixture 509 
of antagomirs directed against let7a-5p and let7c-5p. 510 
 511 
4.5.RNA isolation, qRT-PCR, RNA microarrays and sequencing 512 
Total RNA was isolated using Trizol Reagent (Invitrogen) according to the manufacturer’s instruction. 513 
Total RNA was DNase treated and equal amounts of RNA were transcribed with random hexamer 514 
primers using SuperScript III reverse transcriptase (Invitrogen). qRT-PCRs for miRNA and mRNA 515 
levels were performed on a AB7500 FAST Real-time PCR system, using Taqman Universal PCR 516 
Master mix (Applied Biosystems) and FastStart Universal SYBR Green Master Mix (Roche), 517 
respectively. Primer sequences are available upon request. For miRNA qRT-PCR, the TaqMan 518 
miRNA assay (Applied Biosystems) was used. The transcript levels of mRNA were normalized to 18S 519 
ribosomal RNA, the levels of miRNAs were normalized to sno234. For Agilent mRNA microarrays of 520 
Dgcr8 KO mouse myoblasts and Illumina RNA deep sequencing of human myotubes, RNA was 521 
processed and analyzed at the Functional Genomics Center Zurich. For Illumina RNA deep 522 
sequencing of mouse myotubes and miRNA deep sequencing of mouse myoblasts, RNA was 523 
processed and analysed at LC Sciences (Houston, TX, USA). The sequence results were obtained as 524 
FPKM (fragment per kilobase of exons per million reads) for each transcript. Predicted targets were 525 
downloaded from TargetScan v7.2. 526 
 527 
4.6.Luciferase assays 528 
The full length human myogenin 3’UTR was purchased from Genecopoeia (San Diego, US) in a Dual-529 
Luciferase-Vector (HmiT102716) and transfected into C2C12 cells using lipofectamin 2000 (Life 530 
technologies, #11668-027) along with the miRNA mimics as described above. For myogenin 531 
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promoter, 1300bp upstream of the transcription start site of the human promoter (primers: forward 532 
GCCGCCTCGGAGGAGATTTGGG; reverse CCCCCAAGCTCCAGCAGCCCCT) were cloned into 533 
the pGL3 vector and transfected along with pRLTK as control vector and the indicated antagomirs 534 
into mouse primary myoblasts. For both experiments, growth media was exchanged for differentiation 535 
media 24h after transfection and cells were processed according to the protocol from Dual-Luciferase 536 
Reporter Assay (Promega, #1960) 72 hours after transfection.  537 
 538 
4.7.Glycogen synthesis  539 
The assay was modified from Krützfeldt et al. [78]. Briefly, myoblasts were transfected with either 540 
control or Ant-5x as described above and differentiated for 3 days. Myotubes were then washed with 541 
HEPES-buffered saline (20 mmol/l HEPES, 140 mmol/l NaCl, 5 mmol/l KCl, 2.5 mmol/l MgSO4, 1 542 
mmol/l CaCl2, 0.1% BSA, pH 7.4) and incubated in the same solution with insulin (1,000 nmol/l) for 543 
1 h at 37°C. D-glucose/D-[14C]glucose (5 mmol/l final concentration, 0.3 µCi/well) was added to the 544 
wells for an additional hour. Cells were then washed with ice-cold PBS and lysed in 30% (v/v) KOH. 545 
Small aliquots were removed for Bradford protein analysis. Samples were heated for 30 min at 95°C, 546 
cooled on ice and glycogen was precipitated with 1ml 95% ethanol. After samples were centrifuged 547 
for 5 min at 9,000g, the resulting pellet was resuspended in water. The samples were precipitated one 548 
additional time, centrifuged and pellet resuspended in water. Radioactivity was determined by liquid 549 
scintillation counting. Results are expressed as counts per minute normalized to total protein content. 550 
 551 
4.8.Statistical analyses 552 
Student’s t-tests were analyzed using excel software, classical one-way ANOVA with post tests and 553 
two-way ANOVA as indicated in the figure legends was analyzed using the GraphPad Prism software. 554 
P-values smaller than 0.05 were considered significant. Results are shown as means ± SEM.  555 
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Figure Legends 776 
Figure 1. Genetic deletion of the miRNA pathway induces the gene cluster “focal adhesion” in 777 
proliferating primary myoblasts. A. Myoblast cultures (Pax7CExDgcr8flox/flox) were incubated for 48 778 
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h with tamoxifen to induce Cre recombinase (Dgcr8 KO) or with vehicle (Control). Deletion of Dgcr8 779 
induced a time-dependent decrease of DGCR8 protein (western blotting), miRNA levels (qRT-PCR 780 
normalized for sno234, n=4, control represented by the dashed line) and onset of apoptosis (flow 781 
cytometry for annexin V staining, n=6-11). B. Primary myoblasts were treated as in A and 782 
differentiated into myotubes for 48h four days after the beginning of the tamoxifen incubation (day 4). 783 
Desmin (green), nuclear DAPI ((blue), 20x magnification, scale bar = 50 µm. C. KEGG pathway 784 
analysis of RNA isolated from proliferating Dgcr8 KO and control myoblasts at day 4. D. Expression 785 
of Dcgr8 and members of the KEGG pathway “focal adhesion” in Pax7CExDgcr8wt/wt (control) and 786 
Pax7CExDgcr8flox/flox myoblasts measured using qRT-PCR at day 4 after tamoxifen incubation, n=4. 787 
The dashed line represents incubation with vehicle. All results are shown as mean ± SEM. *: p<0.05, 788 
**: p<0.01, ***: p<0.001, students`s t test. 789 
 790 
Figure 2.  A combination of six miRNAs rescues myotube morphology and reverses induction of 791 
the focal adhesion gene cluster following DGCR8 deletion. Dgcr8 KO and control myoblasts were 792 
transfected with control mimics, the indicated individual 6 miRNA mimics or their combination (6x 793 
miRNA) two days after beginning of the tamoxifen incubation. 24h after transfection, myoblast 794 
differentiation was induced for 48h. Myotube morphology was analyzed using immunofluorescence 795 
for desmin (A) and brightfield microscopy (B), 10x magnification. Scale bar = 50 µm. C. KEGG 796 
pathway analysis of  RNA isolated from control, Dgcr8 myotubes and Dgcr8 myotubes transfected 797 
with the combination of 6 miRNAs. D. RNA levels as determined by RNA deep sequencing in control 798 
and DGCR8 knockout cells with or without transfection of the 6 miRNA mimics, n=3. Shown are all 799 
genes that are significantly upregulated in the knockout cells and significantly downregulated after 800 
transfection with the mimics (q value < 0.05 according to manufacturer`s analysis). 801 
 802 
Figure 3. A combination of five miRNAs accelerates differentiation of human myoblasts and 803 
improves insulin sensitivity downstream of FAK signaling. Human primary myoblasts were 804 
transfected with equal concentrations of control antagomirs or antagomirs against the indicated 805 
miRNAs, either as single antagomirs or in combination (Ant-5x). 24h after transfection, differentiation 806 
26 
 
was induced for two days (A, B, C, E, G) or up to five days (D, F). A. Gene expression of myogenic 807 
regulatory factors and eMHC was analyzed by qRT-PCR and normalized for 18S RNA, n=5. B. 808 
Protein expression of myogenin and eMHC was analyzed by western blot and normalized to GAPDH 809 
(n=4-6). C. Luciferase vectors harboring either the myogenin 3’UTR (n=4) or promoter region (n=5) 810 
were transfected with miRNA mimics or antagomirs respectively. Myogenin mRNA from control and 811 
Ant-5x treated samples was measured by qRT-PCR at the indicated time points following 812 
Actinomycin D administration (n=3). D. Time course of myogenin and eMHC protein expression 813 
during five days of differentiation, normalized to GAPDH (n=4-6). E. Immunofluorescent analysis of 814 
myotube formation using anti-desmin and wheat germ agglutinin (WGA). Fusion index was calculated 815 
as percentage of nuclei present in cells containing at least two nuclei compared to all nuclei per well 816 
(scale bar 100um, n=4). F. Phosphorylation of p38 MAPK, AKT and FAK during the first three days 817 
of differentiation, n=4. G. Insulin-dependent glycogen synthesis, n=3. *: p<0.05, **: p<0.01, ***: 818 
p<0.001, A, B, C: One way-ANOVA with Dunnett`s multiple comparison test, D,E, F: student`s t test. 819 
G: Two way-ANOVA. All results are shown as mean ± SEM. 820 
 821 
Figure 4. Genome-wide identification of differentially expressed genes and miRNA target 822 
regulation after single or combinatorial miRNA inhibition in human myotubes. Human myoblasts 823 
were transfected with the indicated antagomirs and 24h after transfection differentiation was induced 824 
for two days. RNA was isolated for RNA deep sequencing, n=3. A. Circos plot of differentially 825 
expressed genes (p-value < 0.01 and the absolute log2 fold-change >0.5). Each sector of the plot 826 
represents a different antagomir or combination of the antagomirs (ant-5x). Genes with predicted 827 
binding sites for the respective miRNA are grouped under the darker color in each sector. Log2 fold-828 
changes are presented in red (upregulation) or blue (downregulation). Genes differentially expressed in 829 
more than one condition are joined by grey lines or colored lines in case of predicted target genes. B. 830 
Enrichment for the predicted target genes (Targetscan) for the indicated miRNAs was analyzed in the 831 
group of upregulated genes for the different antagomir conditions using Fisher’s Exact Test. C. 832 
Regulation of all predicted target genes after single antagomir treatment was plotted against their 833 
regulation after the combinatorial antagomir treatment (left panels). Full distribution of target gene 834 
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regulation (log ratio) is shown using violin plots (right panels). D. Bar plot of GO terms enriched in 835 
the upregulated genes after combinatorial antagomir transfection. E. Network of miRNAs and their 836 
predicted target genes from the focal adhesion gene cluster. Blue boxes identify predicted target genes 837 
of one miRNA that are significantly upregulated after single and combinatorial antagomir inhibition. 838 
Green boxes indicate genes predicted to be targeted by at least two miRNAs that are significantly 839 
upregulated after the combinatorial antagomir inhibition.  840 
 841 
Figure 5. Combinatorial miRNA inhibition during skeletal muscle regeneration improves muscle 842 
weight and fiber number in young and aged mice in vivo.  Three days following CTX injection in 843 
young mice (A) or aged mice (22 months) (C), TA muscles were injected with either control 844 
antagomir or a cocktail of the five antagomirs (total amount of 7.5ug per injection [32]). A,C. Muscle 845 
weight was measured and muscle cross sections were evaluated 9 days after antagomir injection using 846 
anti-laminin and DAPI immunofluorescence (scale bar 50um, n=5). B. CTX was injected in TA 847 
muscles of young and aged mice and TA muscle weight was measured as percent of total body weight 848 
at the indicated time points. All results are shown as mean ± SEM, and evaluated with student’s t test 849 
*: p<0.05, **: p<0.01, ***: p<0.001, n=6-7. 850 
 851 
Figure 6. Regulation of the focal adhesion complex by a hierarchical network of miRNAs in 852 
myoblasts and its consequences for the myogenic program and insulin-dependent glycogen 853 
synthesis during muscle cell differentiation. The yellow triangle reflects the frequency of miRNA 854 
target gene cooperativity within the miRNA network.  855 
 856 
 857 
Suppl. Figure 1. Strategy to use gene regulation and miRNA library screening in DGCR8 KO 858 
cells for the identification of miRNAs that can reverse the KO phenotype. mRNA profiling in 859 
DGCR8 KO cells identifies significant gene regulation. mRNAs are selected as a readout for miRNA 860 
library screening. miRNAs that reverse the regulation of the readout mRNAs are selected for further 861 
analysis. 862 
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 863 
Suppl. Figure 2. Genetic deletion of DGCR8 induces Thbs-1 and Pai-1 expression in 864 
proliferating myoblasts. Thbs-1 and Pai-1 mRNA levels were compared  by qRT-PCR in control (no 865 
tamoxifen) and Dgcr8 KO (Pax7CExDgcr8flox/flox) myoblasts, n=4. Results are normalized to 18S RNA 866 
and shown as mean ± SEM. *: p<0.05, **: p<0.01, students`s t test. 867 
 868 
Suppl. Figure 3. miRNA composition of three independent mouse myoblast cultures under 869 
proliferating conditions as determined by small RNA sequencing. Pie charts depict miRNA 870 
abundance as percentage of all miRNA reads. 871 
 872 
Suppl. Figure 4. Identification of 6 miRNAs that can reverse the induction of Thbs-1 and Pai-1 873 
in proliferating and differentiating Dgcr8 KO myoblasts. A. Protocol for the transfection of the 874 
miRNA library mimics into myoblasts with (MT) or without (MB) differentiation and subsequent 875 
harvesting of RNA for qRT-PCR analysis. B. Color-coded expression of Thbs1- and Pai-1 as 876 
measured by qRT-PCR analysis normalized for 18S RNA. Results are average of two independent 877 
transfections. miRNAs that showed marked and consistent downregulation for Pai1 or Thbs1 as 878 
described in the results section are highlighted in grey .  879 
 880 
Suppl. Figure 5. miRNA abundance in human and mouse primary myoblasts. Results are 881 
obtained from RNA sequencing experiments. Abundance is shown as percent of all miRNA reads. 882 
Data for human myoblasts are obtained from a previous published study from our group [33]. Results 883 
are the average of three independent primary cell cultures for mouse and for two human myoblast 884 
cultures.  885 
 886 
Suppl. Figure 6. miRNA cooperativity during differentiation of mouse myoblasts. Mouse primary 887 
myoblasts were transfected with control antagomir or antagomirs against the indicated miRNAs, either 888 
as single antagomirs or in combination (ant-5x). Equal total antagomir concentrations were used in 889 
each condition. 24h later, myogenic differentiation was induced for 48 h and MHC protein was 890 
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analyzed by western blotting, normalized to GAPDH. Results are presented as mean±SEM, n=6, 891 
ANOVA with Dunnett’s multiple comparison test, **: p<0.01.  892 
 893 
Suppl. Figure 7. miRNA overexpression using miRNA mimics promotes differentiation in 894 
human primary muscle cells. Human primary myoblasts were transfected with 30nM single or 895 
combined miRNA mimics (individual mimic concentration in 5x = 6nM) and differentiation was 896 
induced 24h later. A. Expression of the indicated markers of muscle differentiation was assayed 48h 897 
after induction of differentiation by qRT-PCR normalized to 18S RNA (n=4 independent primary 898 
cultures) and compared to transfections using control mimics (dashed line). *: p<0.05, **: p<0.01, 899 
****: p<0.0001, one way-ANOVA with Dunnett`s multiple comparison test. B. Overexpression of 900 
mimics was confirmed by Taqman qRT-PCR normalized to sno234 RNA (n=2).  901 
 902 
Suppl. Figure 8. Adding miR-499 antagomirs to the combinatorial inhibition of the set of five 903 
miRNAs does not further improve the myogenic program during human muscle cell 904 
differentiation.  Human primary myoblasts were transfected with equal concentrations of control 905 
antagomirs or antagomirs against the indicated miRNAs. 24h after transfection, differentiation was 906 
induced for two days. Protein expression of eMHC, phosphorylation of FAK, AKT and p38 MAPK 907 
was analyzed by western blot and normalized to GAPDH (n=4). *: p<0.05, **: p<0.01, ****: 908 
p<0.0001, one way-ANOVA with Dunnett`s multiple comparison test. 909 
 910 
Suppl. Figure 9. Cumulative distributions of log2-fold changes of predicted miRNA targets in 911 
human myotubes after single or combinatorial miRNA inhibition. Human myoblasts were 912 
transfected with the indicated antagomirs or their combination (ant-5x) (grey vertical panel on the left) 913 
and RNA was harvested for RNA deep sequencing as described in Fig.4. Cumulative distributions of 914 
mRNA-Seq changes were plotted for the predicted targets of the indicated miRNAs (grey horizontal 915 
panel on top). A combination of predicted targets for miRNAs that are not expressed in myoblasts 916 
were used as control (miR-375-3p, miR-122-5p, miR-7-5p, miR-124-3p). A. Cumulative distributions 917 
for targets of single miRNAs. B. Cumulative distributions for shared targets of two miRNAs 918 
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(combinatorial miRNA target genes). P values were determined by one-sided Kolmogorov-Smirnov 919 
test. Graphs in which the tested miRNA target list matches the antagomir inhibitor and therefore the 920 
largest shift in cumulate distribution fractions are expected are highlighted in orange. C. Differences of 921 
the average CDF (log2-fold) between the indicated miRNA target genes and non-target controls for 922 
the indicated antagomir conditions. 923 
 924 
Suppl. Table 1. KEGG pathway analysis for genes regulated in DGCR8 KO cells with or without 925 
the add-back of six miRNAs.  The table provides a detailed view of the results shown in Figure 1C.  926 
 927 
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Highlights 
• The microRNA pathway is connected to focal adhesion signalling during muscle cell 
differentiation through a small set of microRNAs 
• microRNAs can form hierarchical networks independent of their genomic localization in which 
activity inversely correlates to target gene cooperativity 
• Relieving the regulation of focal adhesion members by microRNA inhibition improves insulin 
signaling and glycogen synthesis in human muscle cells 
• Targeting a microRNA network during muscle regeneration improves muscle formation in 
young and aged mice 
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